{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:56:02Z","timestamp":1789185362119,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR18E030002"],"award-info":[{"award-number":["LR18E030002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2293753"],"award-info":[{"award-number":["T2293753"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52203194"],"award-info":[{"award-number":["52203194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1201200"],"award-info":[{"award-number":["2021YFA1201200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jconrel.2024.08.043","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T03:04:48Z","timestamp":1726801488000},"page":"454-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["In situ formed reactive oxygen species-responsive dipyridamole prodrug hydrogel: Spatiotemporal drug delivery for chemoimmunotherapy"],"prefix":"10.1016","volume":"375","author":[{"given":"Bing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel K.H.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirak K.","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.08.043_bb0005","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0010","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-020-17670-y","article-title":"A decade of immune-checkpoint inhibitors in cancer therapy","volume":"11","author":"Robert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0025","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/acs.accounts.0c00339","article-title":"Local and targeted delivery of immune checkpoint blockade therapeutics","volume":"53","author":"Han","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201808303","article-title":"Tailoring nanomaterials for targeting tumor-associated macrophages","volume":"31","author":"Ovais","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0045","doi-asserted-by":"crossref","first-page":"1900181","DOI":"10.1002\/adtp.201900181","article-title":"Reprogramming tumor associated macrophages toward M1 phenotypes with nanomedicine for anticancer immunotherapy","volume":"3","author":"Xu","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0050","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","article-title":"Macrophage-based approaches for cancer immunotherapy","volume":"81","author":"Anderson","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0055","doi-asserted-by":"crossref","first-page":"2002054","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for Cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001680","article-title":"Engineered multifunctional Nano- and Biological materials for cancer immunotherapy","volume":"10","author":"Brouillard","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1208\/s12248-023-00845-y","article-title":"Targeting macrophages for tumor therapy","volume":"25","author":"Wang","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0070","first-page":"1","article-title":"Engineering cells for therapy and diagnosis","author":"Li","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2016.07.018","article-title":"Macrophage-based cell therapies: the long and winding road","volume":"240","author":"Lee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0085","doi-asserted-by":"crossref","first-page":"eaaz6579","DOI":"10.1126\/sciadv.aaz6579","article-title":"Cellular backpacks for macrophage immunotherapy","volume":"6","author":"Shields","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0090","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.7150\/thno.42385","article-title":"Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202170304","article-title":"Engineering endogenous tumor-associated macrophage-targeted biomimetic Nano-RBC to reprogram tumor immunosuppressive microenvironment for enhanced chemo-immunotherapy","volume":"33","author":"Wang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120542","article-title":"In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy","volume":"268","author":"Zhao","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0105","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/acs.nanolett.9b00021","article-title":"Reprogramming tumor immune microenvironment (TIME) and metabolism via biomimetic targeting Codelivery of Shikonin\/JQ1","volume":"19","author":"Wang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0110","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1021\/acs.nanolett.1c00209","article-title":"Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for Cancer immunotherapy","volume":"21","author":"Wei","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0120","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1002\/anie.202010281","article-title":"Cell death mediated by the Pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy","volume":"60","author":"Wu","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206851","article-title":"Biomineralized two-enzyme nanoparticles regulate tumor Glycometabolism inducing tumor cell Pyroptosis and robust antitumor immunotherapy","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202204904","article-title":"Biodegradable ca Nanomodulators ActivatePyroptosis through mitochondrial ca overload for Cancer immunotherapy","volume":"61","author":"Zheng","year":"2022","journal-title":"Angew. Chem. Int. Edit."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202209379","article-title":"A dual-responsive STAT3 inhibitor Nanoprodrug combined with oncolytic virus elicits synergistic antitumor immune responses by igniting pyroptosis","volume":"35","author":"Su","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208817","article-title":"Ultrasound-amplified Enzyodynamic tumor therapy by perovskite Nanoenzyme-enabled cell Pyroptosis and Cascade catalysis","volume":"35","author":"Chang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0145","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.cmet.2020.11.018","article-title":"Apaf-1 Pyroptosome senses mitochondrial permeability transition","volume":"33","author":"Xu","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0150","doi-asserted-by":"crossref","first-page":"2310364","DOI":"10.1002\/adfm.202310364","article-title":"Combination of cryo-shocked M1 macrophages and Lonidamine Nanodrugs enables potent chemo-immunotherapy","volume":"34","author":"Shi","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0155","article-title":"Engineered nanogels simultaneously implement HDAC inhibition and chemotherapy to boost antitumor immunity pyroptosis","volume":"26","author":"Chen","year":"2022","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jconrel.2023.02.042","article-title":"Postsurgical wound management and prevention of triple-negative breast cancer recurrence with a pryoptosis-inducing, photopolymerizable hydrogel","volume":"356","author":"Mi","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0165","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.jmrt.2023.03.130","article-title":"Recent advances of PVA-based hydrogels in cartilage repair application","volume":"24","author":"Li","year":"2023","journal-title":"J. Mater. Res. Technol."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0170","article-title":"A dual-bioresponsive drug-delivery depot for combination of epigenetic modulation and immune checkpoint blockade","volume":"31","author":"Ruan","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0175","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1021\/jm070311l","article-title":"Synthesis, flow cytometric evaluation, and identification of highly potent dipyridamole analogues as equilibrative nucleoside transporter 1 inhibitors","volume":"50","author":"Lin","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0180","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1021\/acsnano.0c01350","article-title":"3-Bromopyruvate-conjugated Nanoplatform-induced pro-death autophagy for enhanced photodynamic therapy against hypoxic tumor","volume":"14","author":"Deng","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0185","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1039\/C4SC01963F","article-title":"The energy blocker inside the power house: mitochondria targeted delivery of 3-bromopyruvate","volume":"6","author":"Marrache","year":"2015","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0190","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114529","article-title":"CBL0137 activates ROS\/BAX signaling to promote caspase-3\/GSDME-dependent pyroptosis in ovarian cancer cells","volume":"161","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0200","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017089118","article-title":"TAp73 represses NF-\u03baB\u2013mediated recruitment of tumor-associated macrophages in breast cancer","volume":"118","author":"Wolfsberger","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.08.043_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101217","article-title":"CCL8 Promotes Postpartum Breast Cancer by Recruiting M2 Macrophages","volume":"23","author":"Farmaki","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2024.08.043_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2020.101671","article-title":"The CCL2\/CCL7\/CCL12\/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia","volume":"54","author":"Popiolek-Barczyk","year":"2020","journal-title":"Mol. Cell. Probes"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924005935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924005935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:21:46Z","timestamp":1762269706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924005935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"alternative-id":["S0168365924005935"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ formed reactive oxygen species-responsive dipyridamole prodrug hydrogel: Spatiotemporal drug delivery for chemoimmunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}